Perioperative Analgesia by ESP Catheter on Paediatric Recipient for Liver Transplantation

NCT ID: NCT04838314

Last Updated: 2023-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-01

Study Completion Date

2023-08-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pediatric Liver transplantation surgery is associated with moderate to severe postoperative pain that is related to large abdominal incision cutting muscles and fascia and the anterior abdominal wall and drains. Peri-operative pain management after this surgery is centered on intravenous opioids, which cannot provide complete pain relief and are responsible for side effects such as vomiting or respiratory depression. Fifty-two per cent of pediatric patients reported moderate to severe pain on the day of surgery and 33% on day 1. 42% of patients reported vomiting. Increasing interest has focused on opioid sparing analgesic strategies to avoid some of the detrimental side effects of opioids. Recently, the focus has been on postoperative regional analgesia after major pediatric in major thoracic or abdominal surgeries. Thoracic epidural anesthesia or paravertebral blocks are efficacious but raise some concerns related to their potential complications especially in Liver transplantation with the risk of coagulation disorders.

Erector spinae plane block (ESPB) is an interfascial plane block whereby Local anesthestic (LA) is injected beneath the iliocostalis, longissimus, and spinalis muscles to achieve multi metameric analgesia for pediatric thoracic, cardiac, or abdominal surgery.

I Investigators' hypothesis is with efficient peri operative regional analgesia will reduce the opioids consumption, allow a very early extubation after such long surgeries and improve the quality of recovery by reducing the side effects of opioids as sedation. nausea vomiting delay of first intake.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Goals:

Compare quality of analgesia and quality of recovery between bilateral ESP bilateral catheters versus Opioid analgesia in paediatric patients for liver transplantation reduce the peri operative opioid consumption
2. Methodology:

* Selection criteria:

* Age \> 1 to 15 years old
* Have a clinical indication for Liver transplantation ( list for surgeries listed in full proposal)
* Agree to participate in the trial ( Parents or guardians)
* Exclusion criteria:

* Refusal participation.
* Allergy to LA
* Intubated ventilated pre-operation
* Severe coagulation disorder
* Coma
* Prediction of large volume liver implanted
* After surgery performed

* Large volume implanted with a need of post operative controlled ventilation
* Organ failure
* Unstable patient
* Study design: Prospective Randomized Controlled Trial.

Patients who agree to join the study will be randomized into 2 groups:

Group 1 (Control group): standard of care in Liver Transplantation for paediatric recipients: Intra-operative analgesia by Opioid sufentanil and post operative analgesia by patient controled analgesia assisted by nurse opioid morphine based on the protocol established by Prof Lee Vinmec transplantation surgical committee Group 2 (treatment group): Standard peri-operative analgesia for paediatric recipients in institution since we use regional anaesthesia as first line treatment for peri-operative analgesia Bilateral ESP catheters with continuous regional analgesia by infusion of local anesthestic (Ropivacaine) based on the guidelines by paediatric society of anesthesiologists and based on our recent article published in regional anaesthesia and pain medicine

Sample size: We expected to reduce the peri operative opioid consumption by 85% for liver receipt The sample size of 10 patients per group is required to detect such changes assuming a confidence interval of 95% with a power of 90% and alpha = 0.05. Considering 20% of drop-out, the total sample size is 40 patients (20 patients each group)
3. Project outcomes:

The Primary outcome correlation between

* Pain quality evaluated by
* Opioids consumption The secondary outcomes
* Time to extubate
* Time to discharge from Intensive care Unit (ICU) we will create criteria to determinate when patient will discharge from ICU to go to high dependency In most of advanced hospital they don't keep a long time patient in ICU and send the patient to high dependency unit in surgery As in Institution we don't have we will keep the patient in ICU
* Time to discharge from hospital
* Time to first intake
* Any complication related to one type of analgesia

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Transplant Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized controlled prospective trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard of cares

Peri operative analgesia by opioids

Group Type NO_INTERVENTION

No interventions assigned to this group

regional analgesia

Peri operative analgesia by continuous bilateral ESP catheters

Group Type EXPERIMENTAL

regional analgesia

Intervention Type PROCEDURE

Peri operative regional analgesia by bilateral ESP catheter for 72h

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

regional analgesia

Peri operative regional analgesia by bilateral ESP catheter for 72h

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Recipient liver transplantation who accepted to participate ( parents or guardians)

Exclusion Criteria

* Refusal participation.
* Allergy to LA
* Intubated ventilated pre-operation
* Severe coagulation disorder
* Coma
* Prediction of large volume liver implanted
* After surgery performed Large volume implanted with a need of post operative controlled ventilation
* After surgery performed Organ failure
* After surgery performed Unstable patient
Minimum Eligible Age

12 Months

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vinmec Healthcare System

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

philippe Macaire, MD

Role: PRINCIPAL_INVESTIGATOR

VinMEC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VinMec International hospital

Hanoi, , Vietnam

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Vietnam

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VINMEC-LT-REC-PAED

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.